C G Regårdh

3.4k total citations
59 papers, 2.8k citations indexed

About

C G Regårdh is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, C G Regårdh has authored 59 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 18 papers in Oncology and 17 papers in Pharmacology. Recurrent topics in C G Regårdh's work include Pharmacogenetics and Drug Metabolism (15 papers), Analytical Methods in Pharmaceuticals (15 papers) and Drug Transport and Resistance Mechanisms (15 papers). C G Regårdh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Analytical Methods in Pharmaceuticals (15 papers) and Drug Transport and Resistance Mechanisms (15 papers). C G Regårdh collaborates with scholars based in Sweden, United States and Germany. C G Regårdh's co-authors include G. Johnsson, B. Edgar, Peter Langguth, Per Lundborg, Hildegard Spahn‐Langguth, Jonas Lundahl, Constanze Hilgendorf, Elke Lipka, Gordon L. Amidon and Ulf G. Eriksson and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

C G Regårdh

59 papers receiving 2.6k citations

Peers

C G Regårdh
J. H. G. Jonkman Netherlands
Thorir D. Bjornsson United States
Allen J. Sedman United States
Roger K. Verbeeck Belgium
Fakhreddin Jamali Canada
GT Tucker United Kingdom
Aziz Karim United States
Dion R. Brocks Canada
G. Johnsson Sweden
D.D. Breimer Netherlands
J. H. G. Jonkman Netherlands
C G Regårdh
Citations per year, relative to C G Regårdh C G Regårdh (= 1×) peers J. H. G. Jonkman

Countries citing papers authored by C G Regårdh

Since Specialization
Citations

This map shows the geographic impact of C G Regårdh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C G Regårdh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C G Regårdh more than expected).

Fields of papers citing papers by C G Regårdh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C G Regårdh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C G Regårdh. The network helps show where C G Regårdh may publish in the future.

Co-authorship network of co-authors of C G Regårdh

This figure shows the co-authorship network connecting the top 25 collaborators of C G Regårdh. A scholar is included among the top collaborators of C G Regårdh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C G Regårdh. C G Regårdh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilgendorf, Constanze, Hildegard Spahn‐Langguth, C G Regårdh, et al.. (2000). Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport. Journal of Pharmaceutical Sciences. 89(1). 63–75. 366 indexed citations
2.
Neuhoff, Sibylle, et al.. (2000). Affinities at the verapamil binding site of MDR1-encoded P-glycoprotein: drugs and analogs, stereoisomers and metabolites. International Journal of Clinical Pharmacology and Therapeutics. 38(4). 168–179. 45 indexed citations
3.
4.
Ericsson, Hans, Bengt Tholander, & C G Regårdh. (1999). In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. European Journal of Pharmaceutical Sciences. 8(1). 29–37. 53 indexed citations
5.
Ericsson, Hans, et al.. (1999). Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. European Journal of Clinical Pharmacology. 55(1). 61–67. 55 indexed citations
6.
Lundahl, Jonas, C G Regårdh, B. Edgar, & G. Johnsson. (1998). The interaction effect of grapefruit juice is maximal after the first glass. European Journal of Clinical Pharmacology. 54(1). 75–81. 43 indexed citations
7.
Eriksson, Ulf G., Lars Renberg, Ulf Bredberg, Ann‐Catrine Teger‐Nilsson, & C G Regårdh. (1998). Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug. Biopharmaceutics & Drug Disposition. 19(1). 55–64. 19 indexed citations
8.
Spahn‐Langguth, Hildegard, et al.. (1998). Radioligand-Binding Assay Employing P-Glycoprotein-Overexpressing Cells: Testing Drug Affinities to the Secretory Intestinal Multidrug Transporter. Pharmaceutical Research. 15(7). 1001–1006. 41 indexed citations
9.
Ishizaki, Takashi, Dong‐Ryul Sohn, Kaoru Kobayashi, et al.. (1994). Interethnic Differences in Omeprazole Metabolism in the Two S-Mephenytoin Hydroxylation Phenotypes Studied in Caucasians and Orientals. Therapeutic Drug Monitoring. 16(2). 214–215. 92 indexed citations
10.
Rydén, Lars, Hiroyuki Tadokoro, Per‐Ove Sjöquist, et al.. (1991). Pharmacokinetic analysis of coronary venous retroinfusion: A comparison with anterograde coronary artery drug administration using metoprolol as a tracer. Journal of the American College of Cardiology. 18(2). 603–612. 31 indexed citations
11.
Eriksson, Ulf G., et al.. (1991). Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture. Xenobiotica. 21(1). 75–84. 14 indexed citations
12.
Regårdh, C G, et al.. (1990). Pharmacokinetics of pafenolol after IV and oral administration of three separate doses of different strength to man. Biopharmaceutics & Drug Disposition. 11(7). 607–617. 13 indexed citations
13.
Regårdh, C G, et al.. (1990). Pharmacokinetics of pafenolol in the rat: A suitable model for studying absorption mechanisms of a drug exhibiting unusual absorption properties in man. Biopharmaceutics & Drug Disposition. 11(7). 619–631. 7 indexed citations
14.
Abrahamsson, Tommy, et al.. (1988). Binding of the β-blockers timolol and H to ocular melanin. Experimental Eye Research. 47(4). 565–577. 20 indexed citations
15.
Edgar, B., Per Lundborg, & C G Regårdh. (1987). Clinical Pharmacokinetics of Felodipine. Drugs. 34(Supplement 3). 16–27. 63 indexed citations
16.
Edgar, B., Mattias Aurell, G. Johnsson, C G Regårdh, & Charles W. Shansky. (1987). Effects of Impaired Renal Function on the Pharmacokinetics of Felodipine. Drugs. 34(Supplement 3). 31–32. 4 indexed citations
17.
Sutfin, Tamara A., Margareth Gabrielsson, & C G Regårdh. (1987). Effects of biliary excretion on the disposition of felodipine and metabolites in the rat. Xenobiotica. 17(10). 1203–1214. 7 indexed citations
18.
Jordö, L., G. Johnsson, Per Lundborg, & C G Regårdh. (1984). Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol.. PubMed. 22(6). 312–5. 5 indexed citations
19.
Almersjö, O, et al.. (1980). Pharmacokinetic Studies of 5‐Fluorouracil after Oral and Intravenous Administration in Man. Acta Pharmacologica et Toxicologica. 46(5). 329–336. 34 indexed citations
20.
Hoffmann, Kurt, C G Regårdh, Mattias Aurell, Magnar Ervik, & L. Jordö. (1980). The Effect of Impaired Renal Function on the Plasma Concentration and Urinary Excretion of Metoprolol Metabolites. Clinical Pharmacokinetics. 5(2). 181–191. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. H. G. Jonkman Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by Allen J. Sedman Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Fakhreddin Jamali Breakdown of academic impact, for papers by GT Tucker Breakdown of academic impact, for papers by Aziz Karim Breakdown of academic impact, for papers by Dion R. Brocks Breakdown of academic impact, for papers by G. Johnsson Breakdown of academic impact, for papers by D.D. Breimer
Rankless by CCL
2026